What is the catalog number for Annexin A1/ANXA1 Rabbit Polyclonal Antibody?

The catalog number for Annexin A1/ANXA1 Rabbit Polyclonal Antibody is orb215882.

What sizes are available for Annexin A1/ANXA1 Rabbit Polyclonal Antibody?

Annexin A1/ANXA1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Annexin A1/ANXA1 Rabbit Polyclonal Antibody in stock?

Annexin A1/ANXA1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Annexin A1/ANXA1 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Annexin A1; Annexin I; Annexin-1; Calpactin II; Calpactin-2; Chromobindin-9; Lipocortin I; Phospholipase A2 inhibitory protein; p35; ANXA1; ANX1, LPC1

UniProt

P04083

Reactivity

Human, Monkey, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human Annexin A1 recombinant protein (Position: A2-N346) . Human Annexin A1 shares 88% and 89% amino acid (aa) sequences identity with mouse and rat Annexin A1, respectively.

Target

Annexin A1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cell Biology, Immunology & Inflammation, Metabolism Research, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Monkey, Rat Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Rat

Form

Lyophilized

Molecular Weight

39 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.